Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma.

scientific article published on 16 July 2012

Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/1354750X.2012.699554
P698PubMed publication ID22793493

P50authorCoonoor ChandrasekarQ80649310
P2093author name stringQ Ding
O K Idowu
Q Yin
A F G Taktak
P2860cites workAngiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.Q55055140
Cancer-related inflammationQ27860907
Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patientsQ31021361
Prognostic impact of lymphocytes in soft tissue sarcomasQ33813250
The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomasQ33842051
A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patientsQ34041858
YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcomaQ34065323
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomasQ34178633
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysisQ34188723
Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific SurvivalQ34557280
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.Q34627925
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patientsQ35121634
Macrophage infiltration predicts a poor prognosis for human ewing sarcomaQ35168030
Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosisQ35242640
D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcomaQ35579727
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomasQ35661688
Prognostic impacts of hypoxic markers in soft tissue sarcomaQ35789146
Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.Q35803084
Soft-tissue sarcomas in adultsQ36233720
Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patientsQ36612348
Autograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantationQ37878299
Use of inflammatory markers to guide cancer treatment.Q37903224
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancyQ39465507
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agentsQ39581986
The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray studyQ39692688
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancerQ42985641
Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patientsQ43568993
Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancerQ43599505
Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcomaQ44754380
A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth patternQ47387905
Earlier diagnosis of bone and soft-tissue tumoursQ51642229
Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma.Q53390333
Cyclooxygenase-2 is an independent predictor of poor prognosis in uterine leiomyosarcomas.Q53433472
P433issue6
P304page(s)539-544
P577publication date2012-07-16
P1433published inBiomarkersQ4915076
P1476titleClinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma
P478volume17

Reverse relations

cites work (P2860)
Q42378704A Validated Prognostic Biomarker Score for Adult Patients with Nonmetastatic Soft Tissue Sarcomas of the Trunk and Extremities
Q98946368Analysis of prognostic factors in soft tissue sarcoma: Cancer registry from a single tertiary hospital in Indonesia. A retrospective cohort study
Q64096473Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study
Q91947378Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
Q58790889Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma
Q53179198Diagnostic value of neutrophil-lymphocyte and albumin-globulin ratios in canine soft tissue sarcoma.
Q41259916Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
Q42238045Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Q38742533Immune Therapy for Sarcomas
Q41072346Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.
Q89823485Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis
Q64242357Neutrophil: Lymphocyte ratio and oral squamous cell carcinoma: A preliminary study
Q90328743PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC
Q34226276Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis
Q35813764Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma
Q35797850Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma
Q54542035Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas.
Q38719404Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma
Q27022482Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
Q58698876Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection
Q42270431Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy
Q58759331Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysis
Q46838204Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy
Q56511945RETRACTED: Preoperative neutrophil-to-lymphocyte ratio for prognostication of patients with distal bile duct carcinomas undergoing surgery
Q50442804Stewart-Treves syndrome following idiopathic leg lymphoedema: remember sarcoma.
Q43588659The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma
Q37507488The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
Q91615248The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma
Q47338550The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.